142 related articles for article (PubMed ID: 7535829)
1. Antibodies against viral nonstructural proteins in response to infection with poliovirus.
Ehrenfeld E; Brown D; Jia XY; Summers DF
J Infect Dis; 1995 Apr; 171(4):845-50. PubMed ID: 7535829
[TBL] [Abstract][Full Text] [Related]
2. Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.
Martín J; Samoilovich E; Dunn G; Lackenby A; Feldman E; Heath A; Svirchevskaya E; Cooper G; Yermalovich M; Minor PD
J Virol; 2002 Nov; 76(21):10921-8. PubMed ID: 12368335
[TBL] [Abstract][Full Text] [Related]
3. Antibody response of children immunized with poliovaccines: an evaluation using two strains of poliovirus type 1.
Deshpande JM; Dave KH
Indian J Med Res; 1992 Sep; 95():216-20. PubMed ID: 1335965
[TBL] [Abstract][Full Text] [Related]
4. Determination of antigenic properties of vaccine derived poliovirus strains.
Pliaka V; Achilleos C; Kyriakopoulou Z; Tsakogiannis D; Ruether IG; Gartzonica C; Levidiotou-Stefanou S; Markoulatos P
Vaccine; 2010 Dec; 29(1):26-33. PubMed ID: 20974307
[TBL] [Abstract][Full Text] [Related]
5. [Herd immunity against poliomyelitis in children in the Moscow Region].
Seĭbil' VB; Malyshkina LP; Tamazian GV; Konopleva TN; Uspenskaia ES
Vopr Virusol; 2009; 54(6):13-8. PubMed ID: 20030276
[TBL] [Abstract][Full Text] [Related]
6. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
Stagni G; Merletti L; De Rosa F
Boll Ist Sieroter Milan; 1979 Jul; 58(3):210-5. PubMed ID: 229884
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of antibody to poliovirus in England and Wales 1984-6.
White PM; Green J
Br Med J (Clin Res Ed); 1986 Nov; 293(6555):1153-5. PubMed ID: 3021273
[TBL] [Abstract][Full Text] [Related]
8. A seroprevalence study of poliovirus antibody in the population of northern Greece.
Frantzidou F; Diza E; Halkia D; Antoniadis A
Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
[TBL] [Abstract][Full Text] [Related]
9. Poliomyelitis immunity status in Italian and foreign subjects.
Tanzi ML; Bracchi U; Affanni P; Dall'Argine A; Bombarda G; Bellelli E
Ann Ig; 1992; 4(4):191-7. PubMed ID: 1284576
[No Abstract] [Full Text] [Related]
10. Poliovirus neutralization by antibodies to internal epitopes of VP4 and VP1 results from reversible exposure of these sequences at physiological temperature.
Li Q; Yafal AG; Lee YM; Hogle J; Chow M
J Virol; 1994 Jun; 68(6):3965-70. PubMed ID: 7514682
[TBL] [Abstract][Full Text] [Related]
11. The use of antipoliovirus monoclonal antibodies as an improved safety test for oral live poliomyelitis vaccine.
Horie H; Sato M; Doi Y; Hashizume S
Vaccine; 1996 Jan; 14(1):35-41. PubMed ID: 8821647
[TBL] [Abstract][Full Text] [Related]
12. Trial of a supplemental dose of four poliovirus vaccines.
Sutter RW; Suleiman AJ; Malankar P; Al-Khusaiby S; Mehta F; Clements GB; Pallansch MA; Robertson SE
N Engl J Med; 2000 Sep; 343(11):767-73. PubMed ID: 10984564
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
[TBL] [Abstract][Full Text] [Related]
14. A Cluster of Paralytic Poliomyelitis Cases Due to Transmission of Slightly Diverged Sabin 2 Vaccine Poliovirus.
Korotkova EA; Gmyl AP; Yakovenko ML; Ivanova OE; Eremeeva TP; Kozlovskaya LI; Shakaryan AK; Lipskaya GY; Parshina IL; Loginovskikh NV; Morozova NS; Agol VI
J Virol; 2016 Jul; 90(13):5978-88. PubMed ID: 27099315
[TBL] [Abstract][Full Text] [Related]
15. A seroprevalence study of poliovirus antibody against a collection of recombinant and non-recombinant poliovirus vaccine strains in the population of southern Greece.
Pliaka V; Ruether IG; Kyriakopoulou Z; Kioussi P; Plakokefalos E; Megalou M; Pratti A; Levidiotou-Stefanou S; Markoulatos P
Clin Microbiol Infect; 2010 Nov; 16(11):1672-5. PubMed ID: 20148919
[TBL] [Abstract][Full Text] [Related]
16. Poliovirus-specific memory immunity in seronegative elderly people does not protect against virus excretion.
Abbink F; Buisman AM; Doornbos G; Woldman J; Kimman TG; Conyn-van Spaendonck MA
J Infect Dis; 2005 Mar; 191(6):990-9. PubMed ID: 15717277
[TBL] [Abstract][Full Text] [Related]
17. Newcastle Disease Virus-Based Vectored Vaccine against Poliomyelitis.
Viktorova EG; Khattar SK; Kouiavskaia D; Laassri M; Zagorodnyaya T; Dragunsky E; Samal S; Chumakov K; Belov GA
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925653
[TBL] [Abstract][Full Text] [Related]
18. Sero-conversion after oral polio vaccine.
Hardas UD; Pathak AA; Jahagirdar VL
Indian J Pediatr; 1978 Oct; 45(369):310-3. PubMed ID: 220192
[No Abstract] [Full Text] [Related]
19. The final phase of polio eradication: new vaccines and complex choices.
Cochi SL; Linkins RW
J Infect Dis; 2012 Jan; 205(2):169-71. PubMed ID: 22158681
[No Abstract] [Full Text] [Related]
20. Sequential use of inactivated poliovirus vaccine followed by oral poliovirus vaccine in Oman.
Sutter RW; Suleiman AJ; Malankar PG; Mehta FR; Medany MA; Arif MA; Linkins RW; Pallansch MA; El-Bualy MS; Robertson SE
J Infect Dis; 1997 Feb; 175 Suppl 1():S235-40. PubMed ID: 9203722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
